Thyrogen · DIN 02246016 · 0.9 mg/mL · injection Pd-2x1.1mg vial
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Thyrogen · DIN 02246016
Manufacturer: Genzyme Canada Inc.; listing date 2003-04-16
Health Canada: Marketed since 2025-09-16 · brand THYROGEN · ATC H01AB01 THYROTROPHIN ALFA · form Powder for solution · route Intramuscular · ingredients THYROTROPIN ALFA 0.9 MG/VIAL · company Sanofi-aventis canada inc · schedule Prescription, Schedule d
Thyrogen: Formulary list price $1922.34 per unit (the source does not state the unit; exact figure $1922.3400). What the ministry pays, not the patient.
Ministry pays: $1922.3400 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02246016)
Source record
DIN 02246016: Thyrogen
Raw flags: sec3=Y
Item: 682800013; group id 791; item number 1928; lccId None; manufacturer id GZM
Source form: Inj Pd-2x1.1mg Vial Pk; strength: 0.9mg/mL
Recorded listing: General benefit
Source prices (unrounded): $1922.3400; ministry $1922.3400
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02246016
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70142
Shortage status: not checked (no credentials)